| 1 | 93390-71-7 | 1-{3-[(DIETHYLAMINO)METHYL]-4-HYDROXYPHENYL}ETHANONE HYDROCHLORIDE | C13H19NO2 | | | |
| 2 | 93390-81-9 | Caffeine Citrate | C16H15N2O6P | 362.27 | 173-176.5° | |
| 3 | 933911-66-1 | 1,2,4-OXADIAZOLE, 5-(2-CHLOROETHYL)-3-(4-METHOXYPHENYL)- | C11H11ClN2O2 | 238.67 | | |
| 4 | 933911-74-1 | 2-(5-amino-1,3,4-thiadiazol-2-yl)propan-2-ol | C5H9N3OS | 159.20946 | | |
| 5 | 933916-87-1 | 4-methoxy-3-{[4-(2-methoxyphenyl)-1-piperazinyl]methyl}benzaldehyde | C20H24N2O3 | 340.41616 | | |
| 6 | 933916-93-9 | 3-[[4-(2-Fluorophenyl)-1-piperazinyl]methyl]-4-methoxy-benzaldehyde | C19H21FN2O2 | 328.38 | | |
| 7 | 933916-95-1 | 4-(chloromethyl)-6-ethoxy-2H-chromen-2-one | C12H11ClO3 | 238.67 | | |
| 8 | 933918-98-0 | 2-methyl-3-(4-methyl-4H-1,2,4-triazol-3-yl)aniline(SALTDATA: FREE) | C10H12N4 | 188.23 | | |
| 9 | 93392-75-7 | Silane, chloro[2-(dimethylsilyl)-1,1,2-trimethylpropyl]dimethyl- | C10H25ClSi2 | 236.93 | | |
| 10 | 93392-77-9 | Guanidine, N-cyano-N'-(2-iodoethyl)-N''-methyl- | C5H9IN4 | 252.06 | | |
| 11 | 93392-97-3 | 1-(3,4-dihydrobenzo[b][1,4]thiazepin-5(2H)-yl)-3-((3,4-dimethoxyphenethyl)amino)propan-1-one(WXG03178) | C22H28N2O3S | 400.53 | | |
| 12 | 93393-93-2 | METHYL 5-ACETYLAMINOLEVULINATE | C8H13NO4 | 187.19 | | |
| 13 | 933936-59-5 | 4-(4-ethynylbenzyl)Morpholine | C20H21ClN2O3 | 372.85 | | |
| 14 | 93394-39-9 | 3H-Pyrrol-3-one,1,2-dihydro-2,2-dimethyl-1-(1-methylethyl)-(9CI) | C9H15NO | 153.2215 | | |
| 15 | 933940-12-6 | 4-isoxazolecarboxamide, 5-amino-3-(2-methoxyphenyl)- | C11H11N3O3 | 233.22 | | |
| 16 | 933945-46-1 | 1,2,4-OXADIAZOLE, 5-(2-CHLOROETHYL)-3-(4-METHYLPHENYL)- | C11H11ClN2O | 222.67 | | |
| 17 | 933949-26-9 | 4-Amino-2-(propylthio)-5-pyrimidinecarbonitrile | C8H10N4S | 194.26 | | |
| 18 | 933949-39-4 | Methyl 7-cyclopropyl-1-ethyl-2-mercapto-4-oxo-1,4-dihydropyrido[2,3-d]pyrimidine-5-carboxylate | C14H15N3O3S | 305.35 | | |
| 19 | 933949-57-6 | (Z)-2-amino-3-{[(E)-(3-phenoxyphenyl)methylidene]amino}-2-butenedinitrile | C17H12N4O | 288.3 | | |
| 20 | 93395-30-3 | 8-Epicrepiside E | C21H28O9 | 424.44 | | |
| 21 | 93395-31-4 | 8β-(2-Hydroxy-2-methyl-3-oxobutyryloxy)glucozaluzanin C | C26H34O12 | 538.54 | | |
| 22 | 93395-44-9 | (3aS)-3,9a,17bβ,17cβ-Tetrahydro-4,9aα,16-trihydroxy-6,14-bis(hydroxymethyl)-2,3aβ,17-trimethylbenzo[kl]bisbenzofuro[3,2-b:2',3'-i]xanthen-9(3aH)-one | C33H28O9 | 568.57002 | | |
| 23 | 93396-74-8 | 1,3-Distearoyl-2-Elaidoyl Glycerol | C57H108O6 | 889.46 | | |
| 24 | 93397-15-0 | Hypelcin A-IV | | | | |
| 25 | 93397-16-1 | Hypelcin A-II | C88H151N23O24 | 1915.31 | | |
| 26 | 93397-17-2 | Hypelcin A | C89H153N23O24 | 1929.34 | | |
| 27 | 93397-22-9 | (Tert-Butoxy)Carbonyl Phe-D-Phe-OH | C23H28N2O5 | 412.48 | | |
| 28 | 93397-83-2 | N'-ACETYL-1H-INDOLE-3-CARBOHYDRAZIDE | C11 H11 N3 O2 | 217.22 | 240-241 °C(Solv: isopropanol (67-63-0)) | |
| 29 | 93397-90-1 | 9-diethylamino-3-hydroxybenzophenoxazin-5-one | C20H18N2O3 | 334.37 | | |
| 30 | 933979-12-5 | 2-(pyridin-3-yloxy)acetamide | C7H8N2O2 | 152.15062 | | |
| 31 | 93398-55-1 | 1-(2-chloroethyl)-1-nitrosocarbamoylalanine estradiol-17-ester | | | | |
| 32 | 93398-73-3 | 1,6-Hexanediamine, N1,N6-bis(2-oxiranylmethyl)- | C12H24N2O2 | 228.33 | | |
| 33 | 93398-92-6 | Ciprofloxacin Impurity 6 Hemisulfate | | | | |
| 34 | 933981-46-5 | 11H-Pyrrolo[2,1-c][1,4]benzodiazepin-11-one, 1,2,3,5,10,11a-hexahydro-, (11aR)- | C12H14N2O | 202.25 | | |
| 35 | 933982-49-1 | 1,1':4',1''-Terphenyl]-4,4''-dicarboxylic acid, 2'-methyl- | C21H16O4 | 332.35 | | |
| 36 | 933983-75-6 | Gadolinium, [α3,α6,α9-tris[3-[(2,3-dihydroxypropyl)amino]-3-oxopropyl]-3,6,9,15-tetraazabicyclo[9.3.1]pentadeca-1(15),11,13-triene-3,6,9-triacetato(3-)-κN3,κN6,κN9,κN15,κO3,κO6,κO9]- | C35H54GdN7O15 | 970.1 | | |
| 37 | 933983-78-9 | Gadolinium, [α3,α6,α9-tris[3-[(1-deoxy-D-glucitol-1-yl)amino]-3-oxopropyl]-3,6,9,15-tetraazabicyclo[9.3.1]pentadeca-1(15),11,13-triene-3,6,9-triacetato(3-)-κN3,κN6,κN9,κN15,κO3,κO6,κO9]- | C44H72GdN7O24 | 1240.34 | | |
| 38 | 933983-79-0 | Fenchol Impurity 2 | | | | |
| 39 | 933983-81-4 | Captopril Impurity 28 | | | | |
| 40 | 933983-92-7 | Esomeprazole Impurity 181 | | | | |
| 41 | 933984-70-4 | 1H-Pyrazole-3,5-dicarboxylic acid, 4-(phenylmethoxy)-, 3,5-dimethyl ester | C14H14N2O5 | 290.27 | | |
| 42 | 933986-40-4 | 1-(4-Ethynylbenzyl)-4-methylpiperazine | C14H18N2 | 214.31 | | |
| 43 | 933986-59-5 | 4-[(4-Ethynylphenyl)methyl]morpholine | C13H15NO | 201.26 | | |
| 44 | 933986-68-6 | Methanone, (4-?ethynylphenyl)?(4-?hydroxy-?1-?piperidinyl)?- | C14H15NO2 | 229.27 | | |
| 45 | 933986-82-4 | (E)-4-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)phenol | C14H19BO3 | 246.11 | | |
| 46 | 933986-97-1 | 6-(1-Pyrrolidinyl)Pyridine-3-Boronic Acid Pinacol Ester | C15H23BN2O2 | 274.17 | 118-121°C | |
| 47 | 933986-99-3 | 2-dioxaborolan-2-yl)pyridine | C17H27BN2O3 | 318.21888 | | |
| 48 | 933987-10-1 | 4-(N-CyclopentylcarbaMoyl)benzeneboronic acid pinacol ester | C18H28BNO4 | 333 | | |
| 49 | 933988-20-6 | 2-pyridin-3-ylpyrimidine-5-carboxylic acid | C10H7N3O2 | 201.18148 | | |
| 50 | 933988-22-8 | 2-pyridin-2-ylpyrimidine-5-carboxylic acid | C10H7N3O2 | 201.18148 | | |
| 51 | 933988-24-0 | 2-(3-Fluorophenyl)pyrimidine-5-carboxylic acid | C11H7N2O2F | 218.18 | | |
| 52 | 933988-26-2 | 2-(4-Fluorophenyl)pyrimidine-5-carboxylic acid | C11H7FN2O2 | 218.18 | | |
| 53 | 933988-34-2 | 2,5-Pyridinediamine, N2,N2,N5-trimethyl- | C8H13N3 | | | |
| 54 | 933988-73-9 | 2-(3,5-Difluorophenyl)pyrimidine-5-carboxylic acid | C11H6F2N2O2 | 236.17 | | |
| 55 | 933988-75-1 | 2-(2,5-Difluorophenyl)pyrimidine-5-carboxylic acid | C11H6F2N2O2 | 236.17 | | |
| 56 | 933988-81-9 | 4-methyl-2-(3-pyridinyl)-5-pyrimidinecarboxylic acid(SALTDATA: 0.2H2O 0.1NaCl) | C11H9N3O2 | 215.2 | | |
| 57 | 933989-11-8 | Benzenemethanesulfonamide, 3-cyano-N-methyl- | C9H10N2O2S | 210.25 | | |
| 58 | 933989-12-9 | Benzenemethanesulfonamide, 3-(aminomethyl)-N-methyl- | C9H14N2O2S | 214.28 | | |
| 59 | 933989-25-4 | methyl 2-cyanopyrimidine-5-carboxylate | C7H5N3O2 | 163.1335 | | |
| 60 | 933989-32-3 | 3-(Morpholine-4-sulfonyl)benzylamine | C11H16N2O3S | 256.32 | | |
| 61 | 933989-40-3 | 4-methyl-2-(2-pyridinyl)-5-Pyrimidinecarboxylic acid | C11H9N3O2 | 215.21 | | |
| 62 | 933990-52-4 | di-(hydroxymethyl)-thiophene-2-ylanamine | C7H11NO2S | 173.23 | | |
| 63 | 933990-53-5 | di-(hydroxymethyl)-(5-bromothiophene-2-yl)anamine | C7H10BrNO2S | 252.13 | | |
| 64 | 933992-48-4 | (R)-4-Benzyl-2-(quinolin-2-yl)-4,5-dihydrooxazole | C19H16N2O | 288.34 | | |
| 65 | 933992-49-5 | (R)-4-Isopropyl-2-(quinolin-2-yl)-4,5-dihydrooxazole | C15H16N2O | 240.3 | | |
| 66 | 933994-01-5 | (1E)-3,3-difluoro-1-nitroprop-1-ene | C3H3F2NO2 | 123.06 | | |
| 67 | 933994-66-2 | Acetamide, N-(difluoromethyl)-N-phenyl- | C9H9F2NO | 185.17 | | |
| 68 | 933994-74-2 | Benzamide, N-(difluoromethyl)-N-methyl- | C9H9F2NO | | | |
| 69 | 933997-90-1 | (E)-7-Benzylidene-6,7-dihydro-5H-cyclopenta[b]pyridine | C15H13N | 207.27 | | |
| 70 | 933997-91-2 | Quinoline, 5,6,7,8-tetrahydro-8-(phenylmethylene)-, (8E)- | C16H15N | 221.3 | | |
| 71 | 933999-84-9 | Reaction products of hexane-1,6-diol with 2-(chloromethyl)oxirane | | | | |